https://ogma.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 Serum concentrations of selenium and copper in patients diagnosed with pancreatic cancer https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:23842 Wed 09 Mar 2022 16:01:18 AEDT ]]> Summary and recommendations from the Australasian guidelines for the management of pancreatic exocrine insufficiency https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:29219 Thu 28 Oct 2021 12:35:47 AEDT ]]> Weight stabilisation is associated with improved survival duration and quality of life in unresectable pancreatic cancer https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:1481 1 kg lost) or weight stable (≤1 kg lost) after an 8 week nutrition intervention period. Group survival duration (Kaplan Meier) and QoL (EORTC QLQ-C30) were compared. Predictors of weight stability were determined using logistic regression analysis. Results: Patients with weight stabilisation survived longer from baseline (log rank test 5.53, P=0.019). They also reported higher QoL scores (P=0.037) and a greater mean energy intake (P<0.001) at Week 8 than those who continued to lose weight. The absence of nausea and vomiting (OR 6.5, P=0.010) and female gender (OR 5.2, P=0.020) were independent determinants of weight stabilisation. Conclusions: Weight stabilisation over an 8 week period in weight-losing patients with unresectable pancreatic cancer was associated with improved survival duration and QoL.]]> Sat 24 Mar 2018 08:28:12 AEDT ]]> Summary and recommendations from the Australasian guidelines for the management of pancreatic exocrine insufficiency https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:27790 Sat 24 Mar 2018 07:23:23 AEDT ]]>